Posted On: Monday, July 18th, 2016
2016 World Hepatitis Day Events in British Columbia Collected by Pacific AIDS Network FRASER Sponsoring Agency: Stride with Purpose Program at the Lower Mainland Purpose Society When: Thursday, July 28 from 8:00am – 9:00am Where: Lougheed Skytrain Station Event Details: Stride with Purpose will be at the Lougheed Skytrain Station handing out treats and… Read more »
Posted On: Wednesday, May 6th, 2015
In this issue Two new FDA warnings issued for simeprevir FDA grants new breakthrough therapy designation for grazoprevir and elbasvir Good adherence to Harvoni shown in two clinical trials Two new FDA warnings issued for simeprevir Two new warnings for simeprevir (Galexos) have been issued by the U.S. Food and Drug Administration (FDA) about: a… Read more »
Posted On: Thursday, April 23rd, 2015
New and Noteworthy In this issue: Harvoni and sofosbuvir added to formularies in Alberta, Nova Scotia and Saskatchewan Sexual transmission of Hep C linked to anal sex, drug use and lower CD4 count Re-infection is likely the cause of Hep C recurrence after being cured from treatment
Posted On: Wednesday, April 8th, 2015
New warning issued for serious heart problems when Harvoni or sofosbuvir is taken with amiodarone The U.S. Food and Drug Administration (FDA) is warning that serious slowing of the heart rate (symptomatic bradycardia) can occur when the drug amiodarone, which is used to treat an irregular heartbeat, is taken together either with Harvoni or with… Read more »
Posted On: Thursday, April 2nd, 2015
In this issue: HEPATITIS C VIRUS Grazoprevir + elbasvir and other emerging drugs Enter ledipasvir Sirius—ledipasvir + sofosbuvir in cases of severe liver injury Using ledipasvir + sofosbuvir when prior treatment with sofosbuvir failed Grading severe liver disease and predicting survival Ledipasvir + sofosbuvir with or without ribavirin in people with liver transplants Solar-1—ledipasvir +… Read more »
Posted On: Wednesday, March 18th, 2015
New and Noteworthy Holkira Pak cures 94% of people co-infected with Hep C and HIV High cure rates for Harvoni in people co-infected with HIV and Hep C Hep C testing program in an emergency department finds undiagnosed older adults with Hep C
Posted On: Wednesday, March 4th, 2015
New and Noteworthy P.E.I. announces their hepatitis C strategy Community-based program successful at linking people to Hep C testing and care
Posted On: Tuesday, February 24th, 2015
New and Noteworthy Vertical transmission of hepatitis C estimated to occur in over 5% of births in women with hepatitis C According to a systematic review on vertical transmission of hepatitis C, the estimated risk for transmission of hepatitis C to the fetus during pregnancy is 5.8%, reported researchers in Clinical Infectious Diseases. With hepatitis… Read more »
Posted On: Wednesday, February 11th, 2015
Posted On: Saturday, October 11th, 2014
New and Noteworthy CATIE-News: A hepatitis C outbreak among HIV-negative gay men in London, England Some HIV-negative gay men may be at risk for getting hepatitis C. Researchers from London, England found 44 cases of acute Hep C infection in HIV-negative gay men between 2010 and 2014. Among HIV-positive gay men, hepatitis C has been… Read more »
Posted On: Friday, October 3rd, 2014
Take this survey It is 36, mostly multiple choice, questions that are divided into 5 sections. Sections that don’t pertain to you can be easily skipped. The survey’s 5 sections ask about: The impact of hep C on your life (8 questions) Your experience with current hep C treatments (9 questions) The impact on caregivers… Read more »
Posted On: Thursday, August 21st, 2014
New and Noteworthy High risk of Hep C among Vancouver street youth From 2005 to 2011, 940 youth were recruited into the At-Risk Youth Study. All youth completed an initial Hep C test and just over 10% were found to be Hep C positive. Of the 512 Hep C-negative youth who were retested every six… Read more »
